Icon

Movantik - (12.5,25 mg; Tablet, Oral)

Naloxegol Astrazeneca
12.5,25 mg; Tablet, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
None
None None
Used to treat constipation that is caused by prescription pain medicines called opioids, in adults with long-lasting (chronic) pain that is not caused by active cancer.
Yes
****** *** *** **** *** ****. **** ***** * **** ** ** ****** ******* (***** *, ****) *** **** ************ *********. ** ****** **** *** **** **** ****** ** **** ****. ***** ********* ***** * **** ** ** ****** ******* (***** *, ****) *** *** *********. *****, *********** ******* **** *** ****, ***** *** ***** ** ********** *** *** *****. *********** ******* **** ****** *** *********, ***** *** ***** ** ********** *** *** *****.
Movantik Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6
****** ******* *** ********* *** ********* *** ********* *** ********* *** *********
*** **** ******* ******* ******* ******* ******* *******
********* ******* *** ********* *** ********* *** ********* *** ********* *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ********* **** **, **** ******* **** *** ****** **** ****
*** **** *** \ ********* **** **, **** ******* **** *** ****** **** ****
********* ** \ ** *** *, **** ******* **** *** ****** *** ****
  1. *** *, **** : ****** ******** *********** ***** *** **** ** ************* **** ****** ******* (***** *, ****)
  2. *** **, **** : *** **** ******** *********** ***** *** **** ** ************* **** ****** ******* (***** *, ****)
  3. *** **, **** : *********** ***** * **** ******* ****** ** ****** ******* (***** *, ****)
  4. *** **, **** : *********** ***** * **** ******* *** **** ** ****** ******* (***** *, ****)
  5. *** **, **** : ********* ******** *********** ***** **'* **** ** ****** ** ****** ******* (***** *, ****)
  6. *** *, **** : *********** ***** * **** ******* ********* ** ****** ******* (***** *, ****)
  7. *** **, **** : *********** ******* **** *** ****, ***** *** ***** ** ********** *** *** *****.
  8. *** **, **** : *********** ******* **** ******.
  9. *** **, **** : *********** ******* **** ********* **** *********** *****.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.